课题基金 / 基金详情

基于OX40/OX40L介导T细胞-肥大细胞相互作用,研究黄连解毒汤治疗“湿热蕴肤”型特应性皮炎分子机制

批准号:
81903884
项目类别:
青年科学基金项目
资助金额:
20.0 万元
负责人:
陈云龙
依托单位:
学科分类:
中药抗炎与免疫药理
结题年份:
2022
批准年份:
2019
项目状态:
已结题
项目参与者:

项目摘要

结项摘要

项目成果

陈云龙的其他基金

相似基金

相关文献

中文摘要
特应性皮炎(AD)是一种易复发、慢性炎症性疾病。湿热蕴肤型AD多见于儿童及青少年,清热解毒是主要治法。目前其机制研究限于单独对T细胞或者肥大细胞的调节,忽视了两者之间的相互作用/平衡关系。OX40/OX40L是介导T细胞与肥大细胞相互作用的共刺激分子;在儿童及青少年患者中,OX40/OX40L高表达与急性期AD严重程度高度相关。我们前期研究发现,黄连解毒汤能调节AD小鼠体内Th1/Th2平衡,抑制肥大细胞激活。基于此,我们推测黄连解毒汤可通过抑制OX40/OX40L,平衡T细胞与肥大细胞相互作用,改善皮肤微环境发挥治疗AD作用。本研究拟基于OX40/OX40L信号,以T细胞与肥大细胞相互作用为切入点,系统考察AD中T细胞增殖、分化及肥大细胞活化等变化。选择黄连解毒汤为代表药,考察清热解毒对湿热蕴肤AD的治疗作用,阐释清热解毒法干预T细胞免疫应答、肥大细胞介导的过敏反应及两者平衡的作用机制。
英文摘要
Atopic dermatitis (AD) is a complicated, relapsing chronic allergic inflammatory skin disease. Since the pattern of dampness-heat encumbrance of skin usually occurs in children and teenagers, clearing heat and removing toxicity is regarded as one of major therapeutic strategies. A series of reported researches on the underlying mechanisms of its therapeutic effect were focused on T cell or mast cell regulation by these therapeutic strategies in AD, however, ignoring the interaction/balance between T cell and mast cell. It has been shown that OX40/40L is a costimulatory molecule mediating the interaction of T cell and mast cell, and its overexpression highly correlates with severity of lesional skin in children patients with acute AD. Our previous studies found that Huang-Lian-Jie-Du-Extract could regulate balance of Th1/Th2 in AD mice, and inhibit activation of mast cell. Therefore, we hypothesize that Huang-Lian-Jie-Du-Extract could regulate interaction/balance of T cell and mast cell by inhibiting OX40/OX40L expression, further to improve the microenvironment of skin for the treatment of AD. In this study, we would focus on interaction/balance of T cell and mast cell mediated by OX40/OX40L signalling, systematically investigate proliferation and differentiation of T cell and activation of mast cell in AD. In addition, Huang-Lian-Jie-Du-Extract would be selected as the representative to investigate the therapeutic effect of clearing heat and removing toxicity strategy on dampness-heat encumbrance of skin-type AD, further to elucidate the underlying mechanisms of interaction/balance of T cell and mast cell, T cell immune response, mast cell-mediated allergic response.
特应性皮炎(atopic dermatitis,AD)是一种具有遗传倾向的过敏性皮肤病,在婴幼儿中发病率较高。AD是以Th2、Th17亢进的皮肤炎症。Th2、Th17型细胞因子分泌增多可下调表皮屏障蛋白,如兜甲蛋白(Loricrin, LOR)的表达,并且可促进瘙痒相关因子TSLP、IL-13、IL-31分泌。目前,APC-OX40L-OX40-CD4+T细胞轴是目前治疗AD的新靶点,其中,OX40主要在T细胞上表达,其配体OX40L可在肥大细胞上表达。OX40-OX40L的连接可促进T细胞分化为Th1、Th2、Th17,抑制Treg的分化,促进T细胞增殖,抑制肥大细胞脱颗粒。黄连解毒汤广泛应用于各类皮肤病的治疗,尤其是AD及湿疹,且具有影响肥大细胞活化及T细胞分化的作用。因此,我们提出假说认为OX40-OX40L连接所介导的T细胞-肥大细胞相互作用是黄连解毒汤治疗AD的关键途径。本课题研究内容包括以下五个部分:1、黄连解毒汤改善AD小鼠红斑、结痂、渗出、干燥、苔藓化等皮损症状,降低临床评分,改善AD小鼠皮损部位炎性浸润,减小棘层厚度,上调表皮屏障蛋白LOR和AQP3表达;2、黄连解毒汤减少AD小鼠搔抓次数,缓解瘙痒症状,减轻肥大细胞浸润情况,下调瘙痒相关因子TSLP、IL-13、IL-31、H4HR mRNA表达情况;3、黄连解毒汤降低AD小鼠脾脏指数,减少AD小鼠脾脏T细胞向Th2、Th17分化的情况,上调Th1/Th2比例,下调Th17/Treg比例分化;4、黄连解毒汤上调AD小鼠OX40、OX40L表达水平;5、黄连解毒汤促进肥大细胞-CD4+T细胞共培养体系中CD4+T细胞凋亡,促进Treg分化,下调Th17/Treg比例。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Anti-atopic dermatitis effects of dictamni cortex: Studies on in vitro and in vivo experimental models
白皮皮质的抗特应性皮炎作用:体外和体内实验模型的研究
DOI: 10.1016/j.phymed.2020.153453
发表时间: 2021-01-12
期刊: PHYTOMEDICINE
影响因子: 7.9
作者: [Chen, Yunlong, Xian, Yan-Fang, Lin, Zhi-Xiu]
通讯作者: Lin, Zhi-Xiu
基于脂肪酸转运代谢,探讨湿热藴肤型特异性皮炎的“肠-皮”轴连接特征及清热法干预作用
  • 批准号:
    82374114
  • 项目类别:
    面上项目
  • 资助金额:
    49万元
  • 批准年份:
    2023
  • 负责人:
    陈云龙
  • 依托单位:
国内基金
海外基金